Stock Chart
RNA
Type: SELL wallstreet
Strike: $75
Premium: $0.05
Expiry: Jan 15, 2027
Target: $75
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About RNA - Avidity Biosciences, Inc. Common Stock
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
Key Statistics
More RNA Analysis
This RNA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track RNA's price movements with trendlines, gamma walls, and key support/resistance levels.